Literature DB >> 19208339

The mRNA binding proteins HuR and tristetraprolin regulate cyclooxygenase 2 expression during colon carcinogenesis.

Lisa E Young1, Sandhya Sanduja, Kristi Bemis-Standoli, Edsel A Pena, Robert L Price, Dan A Dixon.   

Abstract

BACKGROUND & AIMS: During tumorigenesis, loss of rapid messenger RNA (mRNA) decay allows for overexpression of cancer-associated genes. The RNA-binding proteins Hu antigen R (HuR) and tristetraprolin (TTP) bind AU-rich elements in the 3' untranslated region of many cancer-associated mRNAs and target them for stabilization or rapid decay, respectively. We examined the functions of HuR and TTP during colon tumorigenesis and their ability to regulate cyclooxygenase (COX-2), a mediator of prostaglandin synthesis that increases in the colon tumor microenvironment.
METHODS: We evaluated expression of HuR and TTP during colorectal tumorigenesis and in colon cancer cells and associated them with COX-2 expression. HuR and TTP-inducible cells were created to investigate HuR- and TTP-mediated regulation of COX-2.
RESULTS: In normal colon tissues, low levels of nuclear HuR and higher levels of TTP were observed. By contrast, increased HuR expression and cytoplasmic localization were observed in 76% of adenomas and 94% of adenocarcinomas, and TTP expression was lost in >75% of adenomas and adenocarcinomas. Similar results were obtained for HuR and TTP mRNA levels in normal and staged tumor samples. In both adenomas and adenocarcinomas, COX-2 overexpression was associated with increased HuR and decreased TTP (P < .0001); similar associations were observed in colon cancer cells. HuR overexpression in cells up-regulated COX-2 expression, whereas overexpression of TTP inhibited it; limited TTP expression antagonized HuR-mediated COX-2 overexpression.
CONCLUSIONS: Increased expression of the mRNA stability factor HuR and loss of the decay factor TTP occurs during early stages of colorectal tumorigenesis. These changes promote COX-2 overexpression and could contribute to colon tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19208339      PMCID: PMC3742387          DOI: 10.1053/j.gastro.2009.01.010

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  33 in total

Review 1.  The highways and byways of mRNA decay.

Authors:  Nicole L Garneau; Jeffrey Wilusz; Carol J Wilusz
Journal:  Nat Rev Mol Cell Biol       Date:  2007-02       Impact factor: 94.444

2.  Expression of the ELAV-like protein HuR in human colon cancer: association with tumor stage and cyclooxygenase-2.

Authors:  Carsten Denkert; Ines Koch; Nora von Keyserlingk; Aurelia Noske; Silvia Niesporek; Manfred Dietel; Wilko Weichert
Journal:  Mod Pathol       Date:  2006-06-23       Impact factor: 7.842

Review 3.  mRNA stability and cancer: an emerging link?

Authors:  Don Benjamin; Christoph Moroni
Journal:  Expert Opin Biol Ther       Date:  2007-10       Impact factor: 4.388

Review 4.  The role of prostaglandins and other eicosanoids in the gastrointestinal tract.

Authors:  Dingzhi Wang; Jason R Mann; Raymond N DuBois
Journal:  Gastroenterology       Date:  2005-05       Impact factor: 22.682

5.  Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.

Authors:  Johanna Mrena; Jan-Patrik Wiksten; Alexandra Thiel; Arto Kokkola; Leena Pohjola; Johan Lundin; Stig Nordling; Ari Ristimäki; Caj Haglund
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

6.  Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma.

Authors:  Mira Heinonen; Petri Bono; Kirsi Narko; Sung-Hee Chang; Johan Lundin; Heikki Joensuu; Henry Furneaux; Timothy Hla; Caj Haglund; Ari Ristimäki
Journal:  Cancer Res       Date:  2005-03-15       Impact factor: 12.701

7.  Tristetraprolin recruits functional mRNA decay complexes to ARE sequences.

Authors:  Heidi H Hau; Richard J Walsh; Rachel L Ogilvie; Darlisha A Williams; Cavan S Reilly; Paul R Bohjanen
Journal:  J Cell Biochem       Date:  2007-04-15       Impact factor: 4.429

8.  Comparative expression of tristetraprolin (TTP) family member transcripts in normal human tissues and cancer cell lines.

Authors:  Danielle M Carrick; Perry J Blackshear
Journal:  Arch Biochem Biophys       Date:  2007-04-26       Impact factor: 4.013

9.  ARED 3.0: the large and diverse AU-rich transcriptome.

Authors:  Tala Bakheet; Bryan R G Williams; Khalid S A Khabar
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

10.  A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer.

Authors:  Eike Staub; Jörn Gröne; Detlev Mennerich; Stefan Röpcke; Irina Klamann; Bernd Hinzmann; Esmeralda Castanos-Velez; Benno Mann; Christian Pilarsky; Thomas Brümmendorf; Birgit Weber; Heinz-Johannes Buhr; André Rosenthal
Journal:  Mol Cancer       Date:  2006-09-18       Impact factor: 27.401

View more
  114 in total

Review 1.  Posttranscriptional regulation of cancer traits by HuR.

Authors:  Kotb Abdelmohsen; Myriam Gorospe
Journal:  Wiley Interdiscip Rev RNA       Date:  2010-05-06       Impact factor: 9.957

Review 2.  The roles of TTP and BRF proteins in regulated mRNA decay.

Authors:  Sandhya Sanduja; Fernando F Blanco; Dan A Dixon
Journal:  Wiley Interdiscip Rev RNA       Date:  2011 Jan-Feb       Impact factor: 9.957

3.  The mRNA stability factor HuR inhibits microRNA-16 targeting of COX-2.

Authors:  Lisa E Young; Ashleigh E Moore; Lena Sokol; Nicole Meisner-Kober; Dan A Dixon
Journal:  Mol Cancer Res       Date:  2011-11-02       Impact factor: 5.852

Review 4.  MicroRNA and AU-rich element regulation of prostaglandin synthesis.

Authors:  Ashleigh E Moore; Lisa E Young; Dan A Dixon
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

5.  Stability of the LATS2 tumor suppressor gene is regulated by tristetraprolin.

Authors:  Hyun Hee Lee; Mai-Tram Vo; Hyo Jeong Kim; Unn Hwa Lee; Chae Won Kim; Hong Kyeung Kim; Myoung Seok Ko; Won Hyuck Lee; Seung Joo Cha; Young Joo Min; Dae Hwa Choi; Ho Seok Suh; Byung Ju Lee; Jeong Woo Park; Wha Ja Cho
Journal:  J Biol Chem       Date:  2010-03-24       Impact factor: 5.157

Review 6.  Translating the Untranslated Region.

Authors:  Johannes Schwerk; Ram Savan
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

7.  The mRNA-binding protein HuR promotes hypoxia-induced chemoresistance through posttranscriptional regulation of the proto-oncogene PIM1 in pancreatic cancer cells.

Authors:  F F Blanco; M Jimbo; J Wulfkuhle; I Gallagher; J Deng; L Enyenihi; N Meisner-Kober; E Londin; I Rigoutsos; J A Sawicki; M V Risbud; A K Witkiewicz; P A McCue; W Jiang; H Rui; C J Yeo; E Petricoin; J M Winter; J R Brody
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

8.  Post-transcriptional regulation of MEK-1 by polyamines through the RNA-binding protein HuR modulating intestinal epithelial apoptosis.

Authors:  Peng-Yuan Wang; Jaladanki N Rao; Tongtong Zou; Lan Liu; Lan Xiao; Ting-Xi Yu; Douglas J Turner; Myriam Gorospe; Jian-Ying Wang
Journal:  Biochem J       Date:  2010-02-24       Impact factor: 3.857

Review 9.  Tristetraprolin (TTP): interactions with mRNA and proteins, and current thoughts on mechanisms of action.

Authors:  Seth A Brooks; Perry J Blackshear
Journal:  Biochim Biophys Acta       Date:  2013-02-18

10.  LincRNA-p21 suppresses target mRNA translation.

Authors:  Je-Hyun Yoon; Kotb Abdelmohsen; Subramanya Srikantan; Xiaoling Yang; Jennifer L Martindale; Supriyo De; Maite Huarte; Ming Zhan; Kevin G Becker; Myriam Gorospe
Journal:  Mol Cell       Date:  2012-07-26       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.